Harvard Bioscience (HBIO)
(Delayed Data from NSDQ)
$3.26 USD
-0.02 (-0.61%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $3.26 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth F Momentum C VGM
Price, Consensus and EPS Surprise
HBIO 3.26 -0.02(-0.61%)
Will HBIO be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for HBIO based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for HBIO
Harvard Bioscience (HBIO) Q1 Earnings Match Estimates
Bruker (BRKR) Q1 Earnings Beat Estimates
HBIO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Watch These 5 Technology Stocks for Q1 Earnings: Beat or Miss?
Harvard Bioscience (HBIO) Q2 Earnings and Revenues Lag Estimates
Bruker (BRKR) Surpasses Q2 Earnings and Revenue Estimates
Other News for HBIO
Holley And 2 Other Stocks Under $5 Insiders Are Buying
FlexShopper And 3 Other Stocks Under $5 Insiders Are Buying
Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024
Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024
Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference